Natalia Vladimirovna Artymuk

Prof. Dr. Natalia Vladimirovna Artymuk


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SBS. V. Barinov
S. V. Barinov
NANatalia Vladimirovna Artymuk
Natalia Vladimirovna Artymuk
ONO. N. Novikova
O. N. Novikova
ISI. V. Shamina
I. V. Shamina
YTY. I. Tirskaya
Y. I. Tirskaya
GRGian Carlo Di Renzo
Gian Carlo Di Renzo
To identify risk factors and predictors of pregnancy loss and to compare the efficacy of Arabin’s pessary with cervical cerclage in women at a high risk of pregnancy loss.This was a two-center retr...

1 February 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
NANatalia Vladimirovna Artymuk
Natalia Vladimirovna Artymuk
SKSvetlana Yurevna Khapacheva
Svetlana Yurevna Khapacheva
Background: Pelvic floor dysfunction (PFD) is a multifactorial condition that clinically manifests as the pelvic prolapse, urinary and/or rectal incontinence, and sexual dysfunction. Aim: We aimed to evaluate the efficacy of two pelvic floor trainers for the prevention of PFD in women during the postpartum period. Materials and methods: This was a prospective, randomized, open-label study in 70 women in the postpartum period. Participants were randomized to complete a daily, 20-min set of pelvic floor muscle exercises using the EmbaGYN (UK; Group 1, n = 40) or the Magic Kegel Master device (China; Group 2, n = 40) for 4 weeks. All participants anonymously completed the PFDI-20 questionnaire and FSFI form at baseline and last visit. Pelvic floor muscle strength was measured using the XFT-0010 device. Results: After the completion of the 4-week pelvic floor muscle exercise program, there was a significant decrease in the rates of all PFD symptoms including pelvic organ prolapse and urinary and/or fecal incontinence in both groups. The rates of sexual dysfunction after the exercise program decreased significantly only in Group II (69.4 versus 25.0%; р =.001). After the program, Group I showed a significant reduction in the number of women with symptoms of urgent urinary incontinence versus baseline (35.3 versus 8.8% p = .009). Similarly, the rates of urine loss associated with coughing, sneezing or laughing in Group I decreased from 41.2% at baseline to 11.8% after the program (р =.006) and the rates of urine leakage independent of physical activity from 23.5 to 5.9% (p = .040), respectively. Conclusion: The 4-week postpartum pelvic floor muscle exercise program utilizing the EmbaGYN or Magic Kegel Master device has significantly increased the pelvic floor muscle strength and decreased the symptoms of pelvic organ prolapse, urinary and fecal incontinence. The use of the Magic Kegel Master device significantly reduced the symptoms of sexual dysfunction. The use of the EmbaGYN device was effective in addressing the individual symptoms of urinary incontinence.

22 February 2021 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
BBBelokrinitskaya T.E. Belokrinitskaya
Belokrinitskaya T.E. Belokrinitskaya
NANatalia Vladimirovna Artymuk
Natalia Vladimirovna Artymuk
FFFilippov O.S. Filippov
Filippov O.S. Filippov
FFFrolova N.I. Frolova
Frolova N.I. Frolova

28 December 2022 in Fundamental and Clinical Medicine
Verified
Journal Article
Open access
PDF file
DBD. E. Beglov
D. E. Beglov
NANatalia Vladimirovna Artymuk
Natalia Vladimirovna Artymuk
ONO. N. Novikova
O. N. Novikova
KMK. V. Marochko
K. V. Marochko
YPYa. A. Parfenova
Ya. A. Parfenova
Aim. To evaluate the prevalence of preterm birth and risk factors for extremely preterm, very preterm, and moderate to late preterm birth.Materials and Methods. We retrospectively assessed case histories of 11,500 pregnant women delivered in Kuzbass Regional Children's Clinical Hospital during 2019-2021 and their newborns. Among the studied factors were gestational age, birth weight, sex, 5-minute Apgar score, maternal age (< 20 years, 20-35 years, ≥ 35 years), parity (primiparity or multiparity), active smoking, maternal diseases during pregnancy (gestational hypertension, intrahepatic cholestasis of pregnancy, gestational diabetes mellitus, anemia, gastrointestinal and genitourinary diseases), chorioamnionitis, and pregnancy complications (placental abruption, placenta previa, vaginal bleeding, polyhydramnios), fetal distress, and fetal growth restriction.Results. Prevalence of preterm birth was 8.4%. The potential risk factors for preterm birth were placental abruption, placenta previa, short (< 25 mm) cervix, intrahepatic cholestasis of pregnancy, gestational hypertension, chorioamnionitis, anemia, young (< 20 years) and advanced (≥ 35 years) maternal age, primiparity, active smoking, and fetal distress. Among them, placental abruption, placenta previa, short (< 25 mm) cervix, gestational hypertension, and chorioamnionitis were specific risk factors of extremely preterm and very preterm birth whilst intrahepatic cholestasis of pregnancy was the risk factor of moderate to late preterm birth.Conclusion. Extremely preterm, very preterm, and moderate to late preterm birth have distinct risk factor profiles, highlighting the need for differential pregnancy management strategies.

3 September 2019 in Annals of Critical Care
Verified
Journal Article
Open access
ESE. M. Shifman
E. M. Shifman
AKA. V. Kulikov
A. V. Kulikov
ARAlexander M. Ronenson
Alexander M. Ronenson
IAI. S. Abazova
I. S. Abazova
LAL. V. Adamyan
L. V. Adamyan
IZI. B. Zabolotskikh
I. B. Zabolotskikh
The article observes the main provisions of the clinical recommendations for prevention, anesthesia and intensive care for postpartum hemorrhage. The main risk factors, possible complications, principles of clinical and laboratory diagnosis in this pathology are consistently presented. Particular attention is paid to issues of infusion, transfusion therapy and correction of coagulopathic disorders. The problems of estimating the amount of blood loss, diagnosing disorders of the hemostatic system, regulation of hemodynamics in hemorrhagic shock are discussed. The use of recombinant coagulation factors in coagulopathy on the background of massive blood loss has been substantiated.

2 February 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
NANatalia Vladimirovna Artymuk
Natalia Vladimirovna Artymuk
TBTatiana E. Belokrinitskaya
Tatiana E. Belokrinitskaya
OFOleg S. Filippov
Oleg S. Filippov
NFNataly I. Frolova
Nataly I. Frolova
MSMaria N. Surina
Maria N. Surina
To assess the incidence and perinatal outcomes of COVID-19 in pregnant women in the Far Eastern and Siberian Federal Districts of Russian Federation over 10 months of a pandemic. This was secondary...